SAMANTHA WILLIAMS: Open Payments
NPI 1770952798 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 34 payments from 15 companies in 2025. Trend: 2023 $1,336 · 2024 $1,973 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 4 | $231 |
| Bard Peripheral Vascular, Inc. | 1 | $148 |
| AstraZeneca Pharmaceuticals LP | 3 | $144 |
| Tactile Systems Technology Inc | 1 | $141 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| Novo Nordisk Inc | 4 | $78 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| ABIOMED | 2 | $35 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $33 |
Products named: Assure WCD, Venclose Maven Catheter, Flexitouch Plus, LEQVIO, LOKELMA, CAMZYOS, Ozempic, FARXIGA.
Industry payments across LA — which companies pay providers there.
